Professor Robert Huber offered a conference entitled "The Century of Vision: Protein Structures for Drug Research” on 13 November at the auditorium of the Faculty of Biosciences, in commemoration of its 50th anniversary.
Sculptor Jaume Plensa was awarded an honorary doctorate on 6 November at the UAB after having dedicated his career to "introducing beauty into people's everyday life", according to his acceptance speech.
The FMUAB (Festa Major de la UAB) will once again be held on Thursday 8 November. The campus will be filled with stands, musical performances and cultural, supportive and sports activitieses. This year will be dedicated to refugees, under this year's university motto #UABrefugi: l'Autònoma acull.
From 22 to 26 October the UAB will be holding its 13th Sustainable and Safe Mobility Week with a series of activities aimed at raising awareness about sustainable means of transport.
From 5 to 14 November the UAB campus will host the 2nd edition of the UAB Games with the motto “Mens Sana in Corpore Sano”. These transverse, inclusive and solidarity games include a variety of sports and are open to all community members.
On 6 November, the UAB awards the first of five exceptional honorary doctorates as part of the university's 50th anniversary. The event can be followed on the UAB YouTube Channel.
On Friday 19 October at 12 noon, the d'octubre, a les 12h, the Barcelona Microelectronics Institute branch of the National Microelectronics Centre (IMB-CNM, CSIC), located on the UAB campus, will offer an information session previous to the launching of the BepiColombo mission, with talks from experts who participated in the project. The space probes include components manufactured at the Bellaterra campus.
The UAB Governing Council approves the new Protocol to prevent and act against sexual and sex-based harassment, sexual orientation, gender identity or expression, and male chauvinist violence.
A research team from the IBB-UAB and the ALBA synchrotron is developing a new vaccine concept to protect farmed fish from the main viral diseases affecting them. The alternative proposed by them is an orally administered nanoparticle.